[2017 Round-up] A new classification and class 1 evidence transform clinical practice in epilepsy

Despite great strides in the past decade in understanding the heterogeneous causes and mechanisms underlying epilepsies, their classification and class 1 evidence for therapies have lagged well behind. 2017 saw a leap forward with an updated epilepsy classification and the first class 1 evidence for the efficacy of cannabidiol. Less surprising, but nevertheless important, was class 1 evidence showing that epilepsy surgery in children works. Finally, the burgeoning of gene discovery in epilepsy has had untold success in the severe developmental and epileptic encephalopathies, however, the hardest genetic puzzle to solve has been the common epilepsies with complex inheritance.

Source: Lancet Neurology - December 16, 2017 Category: Neurology Authors: Ingrid E Scheffer Tags: 2017 Round-up Source Type: research